Skip to main content
Signal8

CERO THERAPEUTICS HOLDINGS, INC. (CERO) Form 424B3 — May 29, 2026

$CEROForm 424B3Items 1.01, 2.03, 3.02, 9.01Filed May 29, 2026, 4:15 PM ET0001213900-26-062837Original filing

Cero Therapeutics Holdings, Inc. filed a prospectus supplement to update its S-1 registration statement with a Current Report on Form 8-K dated May 28, 2026. The update discloses the issuance of a convertible promissory note to SRX Health Solutions, Inc. The company sold the note for a purchase price of $750,000, which carries a principal face value of $937,500, effectively representing a 25% discount or original issue discount.

Key figures

Debt Amount
937500
Interest Rate
10
Maturity Date
2027-05-28
Offering Price
0.05
Purchase price
750000
Shares registered
729596950
Conversion discount
80% of 5-day low
Stock price at filing
0.0191
Conversion price floor
0.05
Warrant price at filing
0.0022

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.